BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, is pleased to announce that it has set up an Advisory Board comprising a number of business and academic figures with experience in the development of medical devices and pharmaceuticals, as well as in the biopharmaceutical industry. The purpose of the Advisory Board is to give the Company access to developments in both academic and industrial research and development, as well as market related information.
